Literature DB >> 9240138

Hepatolithiasis associated with cholangiocarcinoma.

C H Su1, Y M Shyr, W Y Lui, F K P'Eng.   

Abstract

BACKGROUND: Intrahepatic stone is common in East Asia. Hepatolithiasis is a risk factor for cholangiocarcinoma but it is difficult to make an accurate diagnosis before operation. The effect of intrahepatic stone on diagnosis, treatment and survival in patients with coexistent cholangiocarcinoma was investigated.
METHODS: Between 1981 and 1994, 33 patients with hepatolithiasis and associated cholangiocarcinoma were identified and compared respectively to 18 patients with intrahepatic cholangiocarcinoma alone.
RESULTS: Patients with intrahepatic stones had a significantly longer duration of symptoms, a higher frequency of previous biliary surgery but a lower rate of preoperative diagnosis. Surgical resection was the treatment of choice and was performed in 18 of 33 patients with cholangiocarcinoma and stones and in nine of 18 with intrahepatic cholangiocarcinoma alone. Significantly inferior 5-year survival rates were found in patients with hepatolithiasis: two of 32 versus four of 14 for all cases and two of 17 versus four of nine for resectable cases (P < 0.05).
CONCLUSION: These survival differences may be attributed to delayed diagnosis, lower diagnostic rate and relatively fewer curative resections in the patients with stone-containing cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240138     DOI: 10.1002/bjs.1800840717

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  30 in total

Review 1.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.

Authors:  William C Palmer; Tushar Patel
Journal:  J Hepatol       Date:  2012-03-13       Impact factor: 25.083

2.  Cholangiocarcinoma in the distal bile duct: a probable etiologic association with choledocholithiasis.

Authors:  Masako Nishimura; Shigeyuki Naka; Kazuyoshi Hanazawa; Toru Tani; Masanobu Fukami; Shinta Okada; Yoshihide Fujiyama
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

3.  Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis.

Authors:  Bong-Wan Kim; Hee-Jung Wang; Wook-Hwan Kim; Myung-Wook Kim
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

Review 4.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

5.  Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoprotein.

Authors:  Yan-Ming Zhou; Jia-Mei Yang; Bin Li; Zheng-Feng Yin; Feng Xu; Bin Wang; Peng Liu; Zhi-Min Li
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 6.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

7.  Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Authors:  Zhiliang Wu; Thidarut Boonmars; Sirintip Boonjaraspinyo; Isao Nagano; Somchai Pinlaor; Anucha Puapairoj; Puangrat Yongvanit; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2011-03-05       Impact factor: 2.289

Review 8.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

9.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

10.  Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.

Authors:  Hyo Jung Kim; Jae Seon Kim; Sang Jun Suh; Beom Jae Lee; Jong-Jae Park; Hong Sik Lee; Chang Duck Kim; Young-Tae Bak
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.